Survival benefits of complete ablation in patients with BCLC stage B hepatocellular carcinoma receiving transarterial chemoembolization and systemic therapy
In patients with BCLC stage B HCC receiving TACE combined with systemic therapy, complete ablation was associated with improved survival and a model to identify patients most likely to benefit from the treatment was developed.